Photonic modulation of EGFR: 280nm low level light arrests cancer cell activation and migration

Overexpression of the Epidermal Growth Factor Receptor (EGFR) by cancer cells is associated with a poor prognosis for the patient. For several decades, therapies targeting EGFR have been designed, including the use of monoclonal antibodies and small molecule tyrosine kinase inhibitors. The use of th...

ver descrição completa

Detalhes bibliográficos
Autor principal: Botelho, C. M. (author)
Outros Autores: Marques, Rogério Filipe Fernandes (author), Viruthachalam, Thiagarajan (author), Gonçalves, Odete Sofia Lopes (author), Vorum, Henrik (author), Gomes, Andreia C. (author), Neves-Petersen, Maria Teresa (author)
Formato: conferencePaper
Idioma:eng
Publicado em: 2017
Assuntos:
Epidermal growth factor receptor
Activation
Arrest
EGFR
EGF
Cancer cells
Photonic Therapy
Cell Migration
Filopodia
Ciências Naturais::Ciências Biológicas
Science & Technology
Texto completo:http://hdl.handle.net/1822/45162
País:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/45162

Texto Completo

http://hdl.handle.net/1822/45162

Registos relacionados